Induction of endotoxin tolerance by pathogenic Neisseria is correlated with the inflammatory potential of lipooligosaccharides and regulated by microRNA-146a

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1768-1777

  Liu, Mingfeng ^a   John, Constance M ^a   Jarvis, Gary A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA-BINDING PROTEINS; ENDOTOXINS; ENZYME ACTIVATION; GONORRHEA; HUMANS; HYDROFLUORIC ACID; IMMUNE TOLERANCE; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID A; LIPOPOLYSACCHARIDES; MENINGITIS, MENINGOCOCCAL; MICRORNAS; MONOCYTES; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894279643     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301648     Document Type: Article

References (51)

1. Stephens, D. S., B. Greenwood, and P. Brandtzaeg. 2007. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210.
2. Lo, H., C. M. Tang, and R. M. Exley. 2009. Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. Lancet Infect. Dis. 9: 418-427.
3. Sprong, T., N. Stikkelbroeck, P. van der Ley, L. Steeghs, L. van Alphen, N. Klein, M. G. Netea, J. W. van der Meer, and M. van Deuren. 2001. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J. Leukoc. Biol. 70: 283-288.
4. Hurley, J. C. 1995. Endotoxemia: methods of detection and clinical correlates. Clin. Microbiol. Rev. 8: 268-292.
5. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J. N. Bruun, S. Halvorsen, and E. Sørensen. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159: 195-204.
6. Hotchkiss, R. S., C. M. Coopersmith, J. E. McDunn, and T. A. Ferguson. 2009. The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 15: 496-497.
7. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30: 475-487.
8. Opal, S. M., P. F. Laterre, B. Francois, S. P. LaRosa, D. C. Angus, J. P. Mira, X. Wittebole, T. Dugernier, D. Perrotin, M. Tidswell, et al; ACCESS Study Group. 2013. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309: 1154-1162.
9. Nahid, M. A., M. Satoh, and E. K. Chan. 2011. MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8: 388-403.
10. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
11. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
12. Taganov, K. D., M. P. Boldin, and D. Baltimore. 2007. MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133-137.
13. Westendorp, R. G., J. A. Langermans, T. W. Huizinga, C. L. Verweij, and A. Sturk. 1997. Genetic influence on cytokine production in meningococcal disease. Lancet 349: 1912-1913.
14. Westendorp, R. G., J. A. Langermans, T. W. Huizinga, A. H. Elouali, C. L. Verweij, D. I. Boomsma, and J. P. Vandenbroucke. 1997. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349: 170-173.
15. van Deuren, M., P. Brandtzaeg, and J. W. van der Meer. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13: 144-166.
16. Bjerre, A., B. Brusletto, E. A. Høiby, P. Kierulf, and P. Brandtzaeg. 2004. Plasma interferon-γ and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit. Care Med. 32: 433-438.
17. Gopinathan, U., R. Ovstebø, O. K. Olstad, B. Brusletto, H. C. Dalsbotten Aass, P. Kierulf, P. Brandtzaeg, and J. P. Berg. 2012. Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes. Infect. Immun. 80: 4046-4054.
18. Lynn, W. A., and J. Cohen. 1995. Adjunctive therapy for septic shock: a review of experimental approaches. Clin. Infect. Dis. 20: 143-158.
19. Zeni, F., B. Freeman, and C. Natanson. 1997. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit. Care Med. 25: 1095-1100.
20. Fox, K. K., J. C. Thomas, D. H. Weiner, R. H. Davis, P. F. Sparling, and M. S. Cohen. 1999. Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. Am. J. Epidemiol. 149: 353-358.
21. Schmidt, K. A., H. Schneider, J. A. Lindstrom, J. W. Boslego, R. A. Warren, L. Van de Verg, C. D. Deal, J. B. McClain, and J. M. Griffiss. 2001. Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers. Sex. Transm. Dis. 28: 555-564.
22. Liu, Y., E. A. Islam, G. A. Jarvis, S. D. Gray-Owen, and M. W. Russell. 2012. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms. Mucosal Immunol. 5: 320-331.
23. Liu, M., C. M. John, and G. A. Jarvis. 2010. Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways. J. Immunol. 185: 6974-6984.
24. John, C. M., M. Liu, and G. A. Jarvis. 2009. Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-α in human monocytes. J. Biol. Chem. 284: 21515-21525.
25. John, C. M., M. Liu, and G. A. Jarvis. 2009. Profiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine induction. J. Lipid Res. 50: 424-438.
26. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. In Methods in Carbohydrate Chemistry. R. L. Whistler, ed. Academic Press, New York, p. 83-91.
27. Nahid, M. A., K. M. Pauley, M. Satoh, and E. K. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance: Implication in Innate Immunity. J. Biol. Chem. 284: 34590-34599.
28. -ΔΔCt Method. Methods 25: 402-408.
29. Fichorova, R. N., P. J. Desai, F. C. Gibson, III, and C. A. Genco. 2001. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect. Immun. 69: 5840-5848.
30. McGee, Z. A., C. M. Clemens, R. L. Jensen, J. J. Klein, L. R. Barley, and G. L. Gorby. 1992. Local induction of tumor necrosis factor as a molecular mechanism of mucosal damage by gonococci. Microb. Pathog. 12: 333-341.
31. Ramsey, K. H., H. Schneider, A. S. Cross, J.W. Boslego, D. L. Hoover, T. L. Staley, R. A. Kuschner, and C. D. Deal. 1995. Inflammatory cytokines produced in response to experimental human gonorrhea. J. Infect. Dis. 172: 186-191.
32. Zughaier, S. M., Y. L. Tzeng, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens. 2004. Neisseria meningitidis lipooligosaccharide structuredependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 72: 371-380.
33. Carter, A. B., M. M. Monick, and G. W. Hunninghake. 1999. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am. J. Respir. Cell Mol. Biol. 20: 751-758.
34. Dean, J. L., S. J. Sarsfield, E. Tsounakou, and J. Saklatvala. 2003. p38 Mitogenactivated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation. J. Biol. Chem. 278: 39470-39476.
35. Clark, A. R., J. L. Dean, and J. Saklatvala. 2003. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett. 546: 37-44.
36. Chen, Z. J. 2005. Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7: 758-765.
37. Mabilleau, G., D. Chappard, and A. Sabokbar. 2011. Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J. Biol. Chem. 286: 3242-3249.
38. Beeson, P. B.; Technical assistance of Elizabeth Roberts. 1947. Tolerance to bacterial pyrogens: I. Factors influencing its development. J. Exp. Med. 86: 29-38.
39. 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. J. Immunol. 161: 1921-1929.
40. Neuder, L. E., J. M. Keener, R. E. Eckert, J. C. Trujillo, and S. L. Jones. 2009. Role of p38 MAPK in LPS induced pro-inflammatory cytokine and chemokine gene expression in equine leukocytes. Vet. Immunol. Immunopathol. 129: 192-199.
41. Nick, J. A., N. J. Avdi, S. K. Young, P. P. McDonald, M. A. Billstrom, P. M. Henson, G. L. Johnson, and G. S. Worthen. 1999. An intracellular signaling pathway linking lipopolysaccharide stimulation to cellular responses of the human neutrophil: the p38 MAP kinase cascade and its functional significance. Chest 116(1, Suppl): 54S-55S.
42. Xiang, Q., L. Wen, M. H. Liu, Y. Zhang, J. F. Qu, and J. Tian. 2009. Endotoxin tolerance of RAW264.7 correlates with p38-dependent up-regulation of scavenger receptor-A. J. Int. Med. Res. 37: 491-502.
43. Nimah, M., B. Zhao, A. G. Denenberg, O. Bueno, J. Molkentin, H. R. Wong, and T. P. Shanley. 2005. Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock 23: 80-87.
44. Wang, J., Y. Ouyang, Y. Guner, H. R. Ford, and A. V. Grishin. 2009. Ubiquitinediting enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J. Immunol. 183: 1384-1392.
45. Fransen, F., S. G. Heckenberg, H. J. Hamstra, M. Feller, C. J. Boog, J. P. van Putten, D. van de Beek, A. van der Ende, and P. van der Ley. 2009. Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 5: e1000396.
46. Al-Suleiman, S. A., E. M. Grimes, and H. S. Jonas. 1983. Disseminated gonococcal infections. Obstet. Gynecol. 61: 48-51.
47. Bleich, A. T., J. S. Sheffield, G. D. Wendel, Jr., A. Sigman, and F. G. Cunningham. 2012. Disseminated gonococcal infection in women. Obstet. Gynecol. 119: 597-602.
48. Quakyi, E. K., H. D. Hochstein, and C. M. Tsai. 1997. Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity. Infect. Immun. 65: 1972-1979.
49. Lu, M., A. W. Varley, S. Ohta, J. Hardwick, and R. S. Munford. 2008. Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection. Cell Host Microbe 4: 293-302.
50. Farley, T. A., D. A. Cohen, and W. Elkins. 2003. Asymptomatic sexually transmitted diseases: the case for screening. Prev. Med. 36: 502-509.
51. Hedges, S. R., D. A. Sibley, M. S. Mayo, E. W. Hook, III, and M. W. Russell. 1998. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections. J. Infect. Dis. 178: 742-751.